Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

1.

Size optimization of synthetic graft copolymers for in vivo angiogenesis imaging.

Weissleder R, Bogdanov A Jr, Tung CH, Weinmann HJ.

Bioconjug Chem. 2001 Mar-Apr;12(2):213-9.

PMID:
11312682
[PubMed - indexed for MEDLINE]
2.

In vivo assessment of vascular endothelial growth factor-induced angiogenesis.

Lewin M, Bredow S, Sergeyev N, Marecos E, Bogdanov A Jr, Weissleder R.

Int J Cancer. 1999 Dec 10;83(6):798-802.

PMID:
10597197
[PubMed - indexed for MEDLINE]
3.

[Inhibitation of tumor angiogenesis, growth and metastasis by blocking VEGF paracrine pathway].

Wang F, Tian YH, Li L, Chen XF, Hu HH, Li CY, Huang Q.

Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2002 Mar;34(2):165-70. Chinese.

PMID:
12006990
[PubMed - indexed for MEDLINE]
4.

A radicicol derivative, KF58333, inhibits expression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor, angiogenesis and growth of human breast cancer xenografts.

Kurebayashi J, Otsuki T, Kurosumi M, Soga S, Akinaga S, Sonoo H.

Jpn J Cancer Res. 2001 Dec;92(12):1342-51.

PMID:
11749701
[PubMed - indexed for MEDLINE]
6.

Tumor microvascular changes in antiangiogenic treatment: assessment by magnetic resonance contrast media of different molecular weights.

Turetschek K, Preda A, Novikov V, Brasch RC, Weinmann HJ, Wunderbaldinger P, Roberts TP.

J Magn Reson Imaging. 2004 Jul;20(1):138-44.

PMID:
15221819
[PubMed - indexed for MEDLINE]
7.

Transforming growth factor-beta and Ras regulate the VEGF/VEGF-receptor system during tumor angiogenesis.

Breier G, Blum S, Peli J, Groot M, Wild C, Risau W, Reichmann E.

Int J Cancer. 2002 Jan 10;97(2):142-8.

PMID:
11774256
[PubMed - indexed for MEDLINE]
8.

Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth.

Fahmy RG, Dass CR, Sun LQ, Chesterman CN, Khachigian LM.

Nat Med. 2003 Aug;9(8):1026-32. Epub 2003 Jul 20.

PMID:
12872165
[PubMed - indexed for MEDLINE]
9.

Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.

Shinkaruk S, Bayle M, Laïn G, Déléris G.

Curr Med Chem Anticancer Agents. 2003 Mar;3(2):95-117. Review.

PMID:
12678905
[PubMed - indexed for MEDLINE]
10.

Clinical experience with angiogenesis signaling inhibitors: focus on vascular endothelial growth factor (VEGF) blockers.

Rosen LS.

Cancer Control. 2002 Mar-Apr;9(2 Suppl):36-44. Review.

PMID:
11965229
[PubMed - indexed for MEDLINE]
11.

The development of [(124)I]iodinated-VG76e: a novel tracer for imaging vascular endothelial growth factor in vivo using positron emission tomography.

Collingridge DR, Carroll VA, Glaser M, Aboagye EO, Osman S, Hutchinson OC, Barthel H, Luthra SK, Brady F, Bicknell R, Price P, Harris AL.

Cancer Res. 2002 Oct 15;62(20):5912-9.

PMID:
12384557
[PubMed - indexed for MEDLINE]
Free Article
12.

In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.

Middeke M, Hoffmann S, Hassan I, Wunderlich A, Hofbauer LC, Zielke A.

Exp Clin Endocrinol Diabetes. 2002 Nov;110(8):386-92.

PMID:
12518248
[PubMed - indexed for MEDLINE]
13.

Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.

Vajkoczy P, Farhadi M, Gaumann A, Heidenreich R, Erber R, Wunder A, Tonn JC, Menger MD, Breier G.

J Clin Invest. 2002 Mar;109(6):777-85.

PMID:
11901186
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin.

Calvo A, Yokoyama Y, Smith LE, Ali I, Shih SC, Feldman AL, Libutti SK, Sundaram R, Green JE.

Int J Cancer. 2002 Sep 20;101(3):224-34.

PMID:
12209972
[PubMed - indexed for MEDLINE]
15.

Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.

von Marschall Z, Scholz A, Cramer T, Schäfer G, Schirner M, Oberg K, Wiedenmann B, Höcker M, Rosewicz S.

J Natl Cancer Inst. 2003 Mar 19;95(6):437-48.

PMID:
12644537
[PubMed - indexed for MEDLINE]
Free Article
16.

Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression.

Li D, Williams JI, Pietras RJ.

Oncogene. 2002 Apr 25;21(18):2805-14.

PMID:
11973639
[PubMed - indexed for MEDLINE]
Free Article
17.

CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.

Ruggeri B, Singh J, Gingrich D, Angeles T, Albom M, Yang S, Chang H, Robinson C, Hunter K, Dobrzanski P, Jones-Bolin S, Pritchard S, Aimone L, Klein-Szanto A, Herbert JM, Bono F, Schaeffer P, Casellas P, Bourie B, Pili R, Isaacs J, Ator M, Hudkins R, Vaught J, Mallamo J, Dionne C.

Cancer Res. 2003 Sep 15;63(18):5978-91. Erratum in: Cancer Res. 2003 Nov 1;63(21):7543.

PMID:
14522925
[PubMed - indexed for MEDLINE]
Free Article
18.

VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors.

Mattila MM, Ruohola JK, Karpanen T, Jackson DG, Alitalo K, Härkönen PL.

Int J Cancer. 2002 Apr 20;98(6):946-51.

PMID:
11948478
[PubMed - indexed for MEDLINE]
19.

Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway.

Wei LH, Kuo ML, Chen CA, Chou CH, Lai KB, Lee CN, Hsieh CY.

Oncogene. 2003 Mar 13;22(10):1517-27.

PMID:
12629515
[PubMed - indexed for MEDLINE]
20.

Quantitative PET imaging of VEGF receptor expression.

Chen K, Cai W, Li ZB, Wang H, Chen X.

Mol Imaging Biol. 2009 Jan-Feb;11(1):15-22. doi: 10.1007/s11307-008-0172-1. Epub 2008 Sep 11.

PMID:
18784964
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk